SHG:688578 - Shanghai Allist Pharmaceuticals Co Ltd

Shanghai Allist Pharmaceutical
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	366.4M 332.7%	42.24M -88.5%	111.16M 163.1%	189.23M 70.2%	217.33M 14.9%	273.28M 25.7%	276.51M 1.2%	472.17M 70.8%	599.13M 26.9%	670.38M 11.9%	742.84M 10.8%	833.64M 12.2%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.32M -2.3%	2.74M 107.3%	5.12M 86.7%	7.42M 44.8%	9.35M 26.0%	9.83M 5.2%	8.37M -14.9%	20.78M 148.4%	22.47M 8.1%	26.26M 16.9%	33.92M 29.2%	34.91M 2.9%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	365.08M 338.1%	39.5M -89.2%	106.03M 168.4%	181.81M 71.5%	207.98M 14.4%	263.45M 26.7%	268.14M 1.8%	451.39M 68.3%	576.66M 27.8%	644.12M 11.7%	708.91M 10.1%	798.74M 12.7%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	173.05M 23.4%	166.29M -3.9%	149.84M -9.9%	165.07M 10.2%	216.5M 31.2%	213.32M -1.5%	255.51M 19.8%	317.35M 24.2%	412.13M 29.9%	463.27M 12.4%	455.67M -1.6%	455.93M 0.1%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	171.72M 23.7%	163.55M -4.8%	144.72M -11.5%	157.66M 8.9%	207.15M 31.4%	203.49M -1.8%	247.14M 21.5%	296.57M 20.0%	389.66M 31.4%	437.01M 12.2%	421.75M -3.5%	421.02M -0.2%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	193.35M -	-124.05M -	-38.68M -	24.16M -	828.8K -96.6%	59.97M 7135.3%	21M -65.0%	154.82M 637.3%	187M 20.8%	207.11M 10.8%	287.16M 38.7%	377.71M 31.5%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	26.76M -	-	-	-	208.41M -	-	-	-	656.14M -
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	213.25M -	-116.63M -	-22.67M -	49.44M -	27.17M -45.0%	76.59M 181.9%	34.88M -54.5%	173.54M 397.6%	202.01M 16.4%	233.75M 15.7%	306.05M 30.9%	350.08M 14.4%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.47 -	-0.26 -	-0.05 -	0.11 -	0.06 -45.5%	0.17 183.3%	0.08 -52.9%	0.38 375%	0.45 18.4%	0.52 15.6%	0.68 30.8%	0.78 14.7%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.47 -	-0.26 -	-0.05 -	0.11 -	0.06 -45.5%	0.17 183.3%	0.08 -52.9%	0.38 375%	0.45 18.4%	0.52 15.6%	0.68 30.8%	0.78 14.7%